Risk Factors Associated With SARS-CoV-2 Breakthrough Infections in Fully mRNA-Vaccinated Individuals: Retrospective Analysis.
Cong LiuJunghwan LeeCasey TaAli SoroushJames R RogersJae Hyun KimKarthik NatarajanJason E ZuckerYehoshua PerlChunhua WengPublished in: JMIR public health and surveillance (2022)
Although we found both mRNA vaccines were effective, Moderna/mRNA-1273 had a lower incidence rate of breakthrough infections. Immunocompromised and male individuals were among the highest risk groups experiencing breakthrough infections. Given the rapidly changing nature of the SARS-CoV-2 pandemic, continued monitoring and a generalizable analysis pipeline are warranted to inform quick updates on vaccine effectiveness in real time.